Siemens is reviewing its majority stake in Healthineers, CFO Handelsblatt has told

MUNICH (Reuters) – Siemens is reviewing the majority stake it holds in its medical technology subsidiary Siemens Healthineers, German technology group CFO Ralph Thomas told Handelsblatt newspaper.

Thomas told Handelsblatt that the cooperation with the manufacturer of MRI machines and laboratory systems is not large enough to justify a capital commitment of 45 billion euros ($46.91 billion), referring to the value of Siemens’ 75% stake.

“We are evaluating the economic opportunities for Siemens AG in the healthcare sector. Then we conclude from this how important the Healthineers program is as an investment. Then we will draw a conclusion from that,” he said, adding that the results will be presented. On Capital Markets Day at the end of 2025.

Siemens AG spun off Erlangen, based in Germany, in 2018 and took it public. So far, Siemens has confirmed that it will retain a majority stake in Siemens Healthineers.

However, Thomas recently expected to sell about 5% of his shares in the foreseeable future to fund the acquisition of US software company Altair.

Thomas said he remained committed to the Mobility Trains division, which investors have repeatedly called for to be spun off.

“The company is in good hands with us. I don’t see any need for us to abandon it at the moment,” he told Handelsblatt newspaper.

($1 = 0.9592 euros)

(Reporting by Alexander Huebner; Writing by Miranda Murray; Editing by Rod Nickel)